Today, an injection was administered to a female patient with peritoneal cancer at a German clinic for two tumors: one tumor had a volume of approximately 40 ml, and a smaller tumor had a volume of about 3 ml. We injected 10 ml and 5 ml of CDS, respectively. The smaller 3 ml tumor only required 1 ml for injection, but I decided to inject 5 ml to ensure that any excess CDS could perfuse a larger, ultrasound-invisible tumor in the abdominal cavity.
About 30 minutes after the injection, ultrasound imaging revealed extensive necrosis in both injected tumors, and two hours later, the necrotic areas had increased further. The patient has since driven home with her daughter, a distance of 100 kilometers.
This peritoneal cancer patient was diagnosed by a Swiss doctor about a year and a half ago, who estimated her survival to be only three months. The doctor prescribed chemotherapy, which led to severe reactions in the patient. Subsequently, she came to the German clinic, where I collaborate, to receive alternative therapy. Aside from the tumors not shrinking, there were no visible signs of weakness in the patient. Today, after approximately 5 minutes of injection treatment (excluding anesthesia), ultrasound assessment showed that most of her tumors were necrotic.
Share this post